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Post-transcriptional mechanismsBcl3 is a member of the IκB family that regulates genes involved in cell proliferation and apoptosis. Recent
reports indicated that Bcl3 is overexpressed in HTLV-1-infected T cells via Tax-mediated transactivation, and
acts as a negative regulator of viral transcription. However, the role of Bcl3 in cellular signal transduction and
the growth of HTLV-1-infected T cells have not been reported. In this study, we showed that the knockdown
of Bcl3 by short hairpin RNA inhibited the growth of HTLV-1-infected T cells. Although phosphatidylinositol-
3 kinase (PI3K) inhibitor reduced Bcl3 expression, inactivation of glycogen synthase kinase 3 (GSK3), an
effector kinase of the PI3K/Akt signaling pathway, restored Bcl3 expression in Tax-negative but not in Tax-
positive T cells. Our results indicate that the overexpression of Bcl3 in HTLV-1-infected T cells is regulated
not only by transcriptional but also by post-transcriptional mechanisms, and is involved in overgrowth of
HTLV-1-infected T cells.nt of Immunology, Graduate
hara, Nakagami-gun, Okinawa
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Human T cell leukemia virus type 1 (HTLV-1) (Poiesz et al., 1980;
Yoshida et al., 1982) is an exogenous human retrovirus that causes
two distinct types of disease: adult T cell leukemia (ATL) (Hinuma
et al., 1981; Yoshida et al., 1984) and HTLV-1-associated myelopathy/
tropical spastic paraparesis (HAM/TSP) (Gessain et al., 1985; Osame
et al., 1986). ATL is an aggressive form of leukemia characterized by
the malignant proliferation of CD4+ T cells infected with HTLV-1,
whereas HAM/TSP is a chronic progressive myelopathy characterized
by spastic paraparesis, sphincter dysfunction and mild sensory
disturbance in the lower extremities (Nakagawa et al., 1995). HTLV-
1 encodes a number of regulatory proteins, i.e. Tax and Rex, as well as
accessory proteins, i.e. p12, p13, p30 and HBZ, which participate in the
life cycle of the virus (Matsuoka and Jeang, 2007). Of these proteins,
the viral oncoprotein Tax has been well characterized as a critical
player in both viral and cellular transcription as well as malignant
transformation. Tax is a transcriptional activator required for efﬁcient
expression of the viral genome through three conserved cyclic AMP
response elements (CREs) located in the transcriptional control region
of the virus, and also activates a variety of intracellular signal
transduction pathways and subsequently deregulates gene expres-
sion though interaction with many different cellular proteins,including several transcription factors such as cAMP response element
binding protein (CREB), NF-κB, serum response factor (SRF), and the
transcriptional inhibitor, IκB (Yoshida, 2001).
B-cell leukemia protein 3 (Bcl3) is a member of the IκB family
initially identiﬁed as a putative proto-oncogene from chronic B-cell
lymphocytic leukemia (McKeithan et al., 1987; Ohno et al., 1990).
Increased Bcl3 expression typically results from chromosomal
translocations and leads to increased cell survival, proliferation, and
malignancy (Courtois and Gilmore, 2006; McKeithan et al., 1987;
Ohno et al., 1990) potential tomorigenesis in many cell types
including T cells (Palmer and Chen, 2008). Furthermore, it has been
reported that respiratory syncytial virus (RSV) infection (Jamaluddin
et al., 2005) and viral oncogenic proteins such as Epstein–Barr virus
(EBV) latent membrane protein (LMP) (Kung and Raab-Traub, 2008;
Nakamura et al., 2008) and Hepatitis B virus X protein (HBX) (Park
et al., 2006) upregulate Bcl3 gene expression through activation of the
NF-κB signaling pathway. In addition to its possible role in
oncogenesis, recent reports also suggest that Bcl3 has an important
function in controlling inﬂammation and autoimmunity mediated by
the NF-κB signaling pathway (Schwarz et al., 1997). Namely, Bcl3-
deﬁcientmice display defects in secondary lymphoid organs including
partial loss of B cells (Franzoso et al., 1997), exhibit severe defects in
humoral immune responses, and in protection from in vivo pathogenic
challenges (Schwarz et al., 1997), and an autoimmune disease-like
phenotype including uncontrolled inﬂammation mediated by aber-
rant inﬂammatory cytokine production (Carmody et al., 2007). Bcl3-
deﬁcient cells derived from Bcl3-deﬁcient mice are hypersensitive to
toll like receptor (TLR) activation and are unable to control responses
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mediated blockade of NF-κB p50 degradation (Carmody et al., 2007).
These observations, especially overexpression of Bcl3 in a number
of cancers including T cell leukemias, prompted us to investigate the
roles of Bcl3 in HTLV-1 infection. In this study, we therefore focus on
the molecular mechanism of Bcl3 protein overexpression in HTLV-1
infection and its effect on overgrowth of HTLV-1 infected cells, which
may help to generate potential strategies for therapy of ATL.
Results
Bcl3 protein is constitutively expressed in HTLV-1-infected T cell lines
Although recent reports indicated that bcl3 mRNA is induced by
HTLV-1 Tax oncoprotein (Hishiki et al., 2007), there is no report
whether Bcl-3 protein is also highly expressed and induced by Tax in
HTLV-1 infected cells. We therefore ﬁrst analyzed both bcl3 mRNA
and protein expression in six HTLV-1-infected and three uninfectedFig. 1.Overexpression of Bcl3 mRNA and protein in HTLV-1-infected T cell lines and HTLV-1
total RNA extracted from HTLV-1-infected (C5/MJ, HUT102, MT-1, MT-2, MT-4, and S
transcription. PCR was then performedwith the primers for Bcl3, Tax, and GAPDH. The arro
panel). The analysis of GAPDH mRNA was included as a loading control. (B) Total cell ly
SLB1) and uninfected (CEM, Jurkat and MOLT-4) T cell lines and applied to Western blo
antibodies (bottom panel). The analysis of GAPDH protein was included as a loading contr
and GAPDH mRNA levels were examined by RT-PCR. (D) JPX-9 cells were treated with 1
protein were examined by Western blot analysis.human T cell lines by RT-PCR and Western blot analysis. Bcl3 mRNA
was expressed in all the six HTLV-infected T cell lines including
MT-1, C5/MJ, HUT102 and MT-4 cells, all of which are not previously
tested (Hishiki et al., 2007), but not in all the three HTLV-1-
uninfected T cell lines tested (Fig. 1A). Similarly, Bcl3 protein was
expressed in all the six HTLV-infected T cell lines, but not in all the
three HTLV-1-uninfected T cell lines (Fig. 1B). The Bcl3 protein was
abundantly expressed in HUT-102, MT-2, and SLB-1 cells, which
express high levels of Tax protein, whereas MT-1 cells, which do not
express Tax protein, also express a low level of Bcl3 protein (Fig. 1B).
These data suggest that although the level of Bcl3 protein expression
is largely dependent on the level of Tax protein expression in most
HTLV-1-infected cell lines, Bcl3 protein expression is alsomaintained in
MT-1 cells in a Tax-independent manner. Next, to examine whether
Bcl3 protein expression is induced by Tax, we used JPX-9 cells, a Jurkat
subclone generated by the stable introduction of a functional Tax
expression-plasmid vector, and induced Tax expression by adding
CdCl2 into the culture medium (ﬁnal concentration: 10 µM). AlthoughTax-mediated induction of Bcl3 mRNA and protein expression. (A) Onemicrogram of
LB1) and uninfected (CEM, Jurkat and MOLT-4) cell lines were used for reverse
whead indicates the Bcl3 (top panel), Tax (middle panel), and GAPDHmRNA (bottom
sates were prepared from HTLV-1-infected (C5/MJ, HUT102, MT-1, MT-2, MT-4, and
t analysis with anti-Bcl3 (top panel) and anti-Tax (middle panel), and anti-GAPDH
ol. (C) JPX-9 cells were treated with 10 µM CdCl2 for the indicated periods. Bcl3, Tax,
0 µM CdCl2 for the indicated periods. The expression levels of Bcl3, Tax, and GAPDH
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and Western blot analysis showed that Bcl3 expression was increased
concomitantly with Tax in JPX-9 cells (Figs. 1C and D).
Tax physically interacts with endogenous Bcl3 protein in human T cell
lines naturally infected with HTLV-1
Although Kim et al. have recently demonstrated that Tax
interacts with Bcl3 protein through the ankyrin repeat domain by
using an in vitro GST-pull down assay and exogenous overexpression
system in 293 T cells (Kim et al., 2008), there is no report describing
the interaction of Tax with Bcl3 in human T cells naturally infected
with HTLV-1. We ﬁrst conﬁrmed the Bcl3 and Tax interaction byFig. 2. Tax interactswith Bcl3 protein by using an exogenous overexpression system in 293 T ce
vector. (A) Total cell lysateswere prepared and immunoprecipitatedwith anti-Bcl3 antibody or
polyacrylamide gel) and immunoblottedwith anti-Tax antibody. (B) Total cell lysateswere prep
immunoprecipitates were resolved by SDS-PAGE (15% polyacrylamide gel) and immu
immunoprecipitation was also analyzed by Western blotting with anti-Tax and Bcl3 antibodies
HTLV-1 infected and Tax-positive T cell lines MT-2 (D) and HUT102 (E) were lysed and immuno
antibody. Total cell lysates of each T cell lines were prepared separately and included as an indioverexpression in 293 T cells. 293 T cells were transfected with
pcDNA3–Bcl3 and/or pHβPr–1Tax1 and each lysate was divided into
two. Each lysate was immunoprecipitated with anti-Bcl3 or anti-Tax
antibody and subjected to Western blot analysis with anti-Tax or
anti-Bcl3 antibody, respectively. As expected, Tax and Bcl3 proteins
were immunoprecipitated with anti-Bcl3 or Tax antibody, but not
with each control antibody (Figs. 2A and B). 1% aliquot of the lysates
removed before immunoprecipitation was also analyzed byWestern
blotting with anti-Tax and anti-Bcl3 antibodies (Fig. 2C). Next, we
also investigated whether Tax physically interacts with endogenous
Bcl3 protein in HTLV-1-infected T cells. The cell lysates of MT-2 and
HUT102, which have high expression of Tax protein, were subjectedlls. 293 T cellswere transfectedwith 1 µg of pcDNA3–Bcl3 and pHβPr–1Tax1-neo or empty
preimmune rabbit serum, then the immunoprecipitateswere resolved by SDS-PAGE (15%
ared and immunoprecipitatedwith anti-Tax antibody or preimmunemouse IgG, then the
noblotted with anti-Bcl3 antibody. (C) 1% aliquot of the lysates removed before
. Tax protein physically interacts with endogenous Bcl3 protein in HTLV-1-infected T cells.
precipitated with anti-Bcl3 or preimmune rabbit serum, and immunoblotted with anti-Tax
cator for the position of Tax protein in each Western blot.
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Western blot analysis using anti-Tax antibody. As expected, Tax
was immunoprecipitated with anti-Bcl3 antibody both in HUT102
(Fig. 2D) and MT-2 (Fig. 2E) cells, indicating that the physical
interaction of Tax with Bcl3 protein is occur naturally in HTLV-1-
infected T cells.Suppression of Bcl3 protein expression inhibits cell growth of
HTLV-1-infected T cell lines
It has been reported that the control of cell cycle progression is
deregulated in HTLV-1 infected T cell lines (Akagi et al., 1996;Marriott
and Semmes, 2005; Suzuki et al., 1996). Also, Bcl3 has been shown to
enhance cell cycle progression (Massoumi et al., 2006; Ohno et al.,
1990; Rocha et al., 2003; Westerheide et al., 2001). To examine the
role of Bcl3 in the growth of HTLV-1-infected T cells, a lentivirus-
based RNA interference system was used to knock down Bcl3
expression in three HTLV-1-infected T cell lines (HUT102, C5/MJ
and MT-4). Lentiviruses encoding shRNA against Bcl3 together with a
puromycin resistance gene were used to transduce each HTLV-1
infected T cell line, and the cells were cultured in the presence of
puromycin for 2 days. Western blot analysis showed the suppression
of Bcl3 protein expression with a Bcl3 shRNA virus, but not in those
treated with a control virus (Fig. 3A). Meanwhile, the cell growth was
signiﬁcantly inhibited in HUT102, C5/MJ and MT-4 cells infected with
Bcl3 shRNA lentivirus as compared with those infected with the
control lentivirus (Fig. 3B). These results indicated the suppressive
role of Bcl3 protein in the growth of HTLV-1-infected T cells.Fig. 3. Knock-down of Bcl3 expression suppressed cell growth of HTLV-1-infected T cells. (A
human Bcl3 or control shRNA, or remained uninfected as a control of parental cells, then c
puromycin for another 2 days other than the control of parental cells. After the selection with
Bcl3 (top) and anti-Tax (middle), and anti-GAPDH (bottom) antibodies. (B) The effect of shR
trypan blue dye exclusion method. Error bars indicate standard deviations of the results of tw
MJ or MT-4 cells. Non-targeted: HUT102, C5/MJ or MT-4 cells infected with lentivirus encod
lentivirus encoding shRNA against human Bcl3. *: Pb0.01.The constitutive expression of Bcl3 protein is maintained by the
posttranslational regulation through PI3K/Akt signaling pathway in
HTLV-1-infected T cell lines
Since previous reports have shown that the activation of PI3K/Akt
signaling pathway inhibits the Bcl3 protein degradation (Viatour
et al., 2004) and PI3K/Akt signaling pathway is constitutively
activated in HTLV-1-infected T cells (Ikezoe et al., 2007; Jeong et al.,
2005; Tomita et al., 2006), we examined whether overexpression of
Bcl3 protein in HTLV-1-infected T cells is maintained by the
posttranslational regulation via activation of PI3K/Akt signaling
pathway, as well as the Tax-mediated transcriptional activation of
Bcl3 gene (Hishiki et al., 2007; Kim et al., 2008). Both Tax-negative
HTLV-1-infected T cell line MT-1 and Tax-positive HTLV-1-infected T
cell line MT-2 were treated with 20 µM of PI3K inhibitor LY294002 or
its solvent DMSO for 6 h in the presence of 50 µg/ml cycloheximide
(CHX) to block new protein synthesis. MG132, an inhibitor of 20 S
proteasome mediated ubiquitin-dependent protein degradation, was
used as a negative control of the Bcl3 protein degradation in the
presence of CHX. In Tax-positive MT-2 cells, although Bcl3 protein
expression was signiﬁcantly reduced in the presence of 20 µM
LY294002, such degradation was prevented by the MG132 treatment
(Fig. 4A, the top). In contrast, Bcl3 protein expression was not
signiﬁcantly changed in the presence of 20 µM LY294002 but
increased in the presence of 20 µM MG132 in Tax-negative MT-1
cells. Meanwhile, in Tax-positive MT-2 cells, phosphorylation of both
Ser473 and Thr308 residues in Akt protein was inhibited by LY294002
(Fig. 4A, second and third from the top) whereas the Tax protein
expression was not signiﬁcantly changed by the LY294002 and) HUT-102, C5/MJ or MT-4 cells were infected with lentivirus encoding shRNA against
ultured for 2 days. The infected cells were further cultured in the presence of 1 µg of
puromycin, total cell lysates were prepared and applied toWestern Blotting with anti-
NA on cell growth was examined by counting the viable cell number in triplicate by the
o independent experiments performed in triplicate. Parental: uninfected HUT102, C5/
ing control shRNA. Bcl3 KD (knockdown): HUT102, C5/MJ or MT-4 cells infected with
Fig. 4. The constitutive expression of Bcl3 protein is regulated by the activation of PI3K/Akt signaling pathway and Tax enhances inhibition of Bcl3 protein degradation inHTLV-1-infected
T cells. (A) MT-1 and MT-2 cells were treated with 20 µM each of PI3K inhibitor LY294002 or proteasome inhibitor MG132, or DMSO in the presence of 50 µg/ml CHX for 6 h. Total cell
lysates were analyzed by Western blot analysis with anti-Bcl3, anti-phosphorylated Akt (Ser473), anti-phosphorylated Akt (Thr308), anti-Akt, anti-Tax, and anti-GAPDH antibodies, as
indicated. (B)MT-1 andMT-2 cells were treatedwith 10 mMLiCl for 6 h and total cell lysateswere analyzed byWestern blot analysiswith anti-Bcl3, anti-Tax, and anti-GAPDH antibodies,
as indicated.
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MT-1 cells, phosphorylation of both Ser473 and Thr308 residues in
Akt protein was not detected. These data suggest that the over-
expression of Bcl3 protein is maintained by the activation of PI3K/Akt
signaling pathway in Tax-positive but not in Tax-negative HTLV-1
infected T cell lines.
Previous reports indicated that the glucose synthase kinase 3
(GSK3) mediates the Bcl3 protein degradation (Viatour et al., 2004),
and that GSK3 remains activated in Tax-negative HTLV-1-infected T
cell line MT-1 but is fully inactivated in the Tax-positive HTLV-1-
infected T cell line MT-2 (Tomita et al., 2006). Therefore, to examine
the effect of Tax for the Bcl3 protein degradation, we compared theFig. 5. Schematic representation of the mechanisms of Bcl3 protein accumulation in
HTLV-1 infected T cells. Tax transactivates Bcl3 gene transcription through NF-κB
pathway. Tax also enhances the inhibition of Bcl3 protein degradation through
activating PI3/Akt signaling pathway and subsequent inactivation of GSK3. Inactivation
of GSK-3 prevents proteosomal degradation of Bcl3. The words in parentheses are the
names of the inhibitors for each site of action (see Fig. 4).degree of Bcl3 protein degradation mediated by GSK3 between Tax-
negative MT-1 and Tax-positive MT-2 cells. When the cells were
treated by lithium chloride (LiCl), which acts as a speciﬁc inhibitor of
GSK3, we observed the accumulation of Bcl3 protein in Tax-negative
MT-1 cells in a time-dependent manner, whereas the level of Bcl3
protein was not signiﬁcantly changed in the Tax-positive MT-2 cells
(Fig. 4B, top panel). These results indicated that LiCl increases Bcl3
protein levels in cells with activated GSK3, but not in cells with
inactive GSK3, because of constitutive activation of PI3K/Akt signaling
pathway by Tax (Fig. 5).
Discussion
Recently, Hishiki et al. reported that bcl3 mRNA is constitutively
expressed in three HTLV-1 infected T cell lines (MT-2, C91-PL and SLB-1)
but not in two HTLV-1-uninfected human leukemic T cell lines (Jurkat
and JPX-9). They also reported that bcl3 mRNA expression was induced
in JPX-9 cell line treated with CdCl2 along with the induction of viral
transactivator Tax (Hishiki et al., 2007). Since one NF-κB site within
intron 2 acts as a transcriptional enhancer of Bcl3 gene in Jurkat T cells
stimulated with phorbol myristate acetate (PMA) and ionomycin, which
is mimicking T cell receptor activation (Ge et al., 2003), it is likely that
bcl3 overexpression is maintained by Tax-dependent mechanism.
Indeed, Kim et al. have recently demonstrated that Tax mediates Bcl3
induction by intronic enhancers through activation of NF-κB signaling
pathway in Jurkat T cells (Kim et al., 2008). In this study, we ﬁrst
conﬁrmed Bcl3 overexpression by using different cell lines both mRNA
and protein levels. As expected, both Bcl3 mRNA and protein were
overexpressed in ﬁve Tax-positive and one Tax-negative HTLV-1 infected
T cell lines but not in three HTLV-1 uninfected T cell lines, and both Bcl3
mRNA and protein expression were induced along with the induction of
Tax in JPX-9 cells.
The identiﬁcation of Tax interacting proteins has been extensively
performed, and numerous cellular proteins including transcriptional
factors and cell signaling mediators have been reported (Sun and
Yamaoka, 2005). It is therefore believed that the interaction of Tax
with those cellular proteins has critical roles in Tax-mediated cell
immortalization and transformation as well as tomorigenesis (Giam
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Tax and Bcl3 by artiﬁcial experimental systems employing over-
expression in 293 T cells or GST-pull down assay (Kim et al., 2008) but
not in human T cells naturally infectedwith HTLV-1, we demonstrated
that Tax physically interacts with Bcl3 protein also in HTLV-1-infected
T cell lines. It has been reported that the G1 to S transition in the cell
cycle is enhanced by transcriptional upregulation of G1 cyclins
including Cyclin D1 and D2 in HTLV-1 infected T cells (Neuveut and
Jeang, 2002), and the activation of NF-κB signaling pathway is critical
for upregulation of those G1 cyclins and cell growth promotion in
HTLV-1 infected T cells (Sun and Yamaoka, 2005). Moreover, Mori
et al. reported that both Cyclin D1 and D2 mRNAs were expressed at
markedly higher levels in all HTLV-I-infected T cell lines (MT-2, MT-4,
C5/MJ, SLB-1, and HUT102) than in any uninfected T cell lines (Jurkat,
MOLT4, and CCRF-CEM), and Tax activated Cyclin D1 and D2
promoters mainly through NF-κB. Interestingly, expression of Cyclin
D1 and D2 proteins concomitantly increased in JPX-9 cells after
treatment with CdCl2, whereas the expression of Tax was not
associated with any concomitant change in Cyclin D3 expression.
Since Bcl3 has an important role in cell cycle progression by inducing
Cyclin D1 gene expression (Westerheide et al., 2001), and also in
tumorigenesis through NF-κB signaling pathway (Courtois and
Gilmore, 2006; Kerr et al., 1992; Massoumi et al., 2006; Ohno et al.,
1990), these observations suggest that constitutive expression of Bcl3
may promote cell cycle progression via upregulation of G1 cyclins
through NF-κB signaling pathway in HTLV-1 infected T cells, although
further studies are needed to clarify this point.
Previous report indicated that the GSK3-mediated Bcl3 protein
degradation is induced by inhibition of de novo protein synthesis with
cycloheximide (CHX), and this degradation is inhibited by the
activation of PI3K/Akt signaling pathway in 293 T cells (Viatour
et al., 2004). On the other hand, previous report also indicated that
Tax enhances the inactivation of GSK3 to inhibit β-catenin protein
degradation through PI3K/Akt signaling pathway in HTLV-1-infected
T cell line (Tomita et al., 2006). We therefore compared the effects of
PI3K/Akt inhibitor LY294002 and GSK3 inhibitor LiCl on both Tax-
negative (MT-1) and Tax-positive (MT-2) HTLV-1 infected human T
cell lines. As a result, consistent with these observations, our data
indicated that PI3K/Akt inhibitor LY294002 induced the Bcl3 protein
degradation in Tax-positive but not Tax-negative HTLV-1 infected T
cell lines whereas treatment of GSK3 inhibitor LiCl enhanced the
accumulation of Bcl3 protein in Tax-negative (i.e. GSK3 active) but not
in Tax-positive (i.e. GSK3 inactive) HTLV-1-infected T cells. Namely, as
well as the Tax-mediated transcriptional activation of Bcl3 gene
(Hishiki et al., 2007; Kim et al., 2008), overexpression of Bcl3 protein
in HTLV-1-infected T cells is also maintained by the posttranslational
regulation via inhibition of Bcl3 degradation through activation of
PI3K/Akt signaling pathway and inactivation of GSK3 in Tax-positive
but not Tax-negative HTLV-1-infected T cells. Since our data showed
that the levels of Bcl3 protein in HTLV-1 infected T cells do not
correlate with the expression levels of Tax protein, and a low level of
Bcl3 protein was expressed also in Tax-negative MT-1 cells, Bcl3
protein expression is maintained in MT-1 cells in a Tax-independent
manner. Recently, Kim et al. reported that Tax interacts with Bcl3
protein and that the ankyrin repeat domain is necessary and sufﬁcient
for inhibition of HTLV-1 LTR promoter activation (Kim et al., 2008),
whereas Hishiki et al. demonstrated that the interaction of Bcl3 with
transducer of regulated CREB-binding proteins-3 (TORC-3) through
the ankyrin repeat domain represses the transactivation of HTLV-1
LTR in a Tax-independent manner (Hishiki et al., 2007). These results
indicate that Bcl3 functions as a repressor of HTLV-1 LTR through the
ankyrin repeat domain both in Tax-dependent and independent
manners. In this study, we further showed that an overexpression of
Bcl3 protein in HTLV-1-infected T cells is also maintained by the
posttranslational regulation via inhibition of Bcl3 degradation
through activation of PI3K/Akt signaling pathway and subsequentinactivation of GSK3 in Tax-positive HTLV-1-infected T cells. These
data suggest that the mechanisms of Bcl3 upregulation and its
stabilization are complex and different in each HTLV-1 infected T cell
line, therefore the levels of Bcl3 protein do not simply correlate with
the levels of Tax protein.
In summary, Bcl3 is constitutively expressed in HTLV-1 infected T
cells by at least two Tax-mediated mechanisms, i.e. transactivation of
Bcl3 gene expression (Kim et al., 2008) and posttranslational
upregulation of Bcl3 protein through the activation of PI3K/Akt
signaling pathway. Although the precise mechanism remains unclear,
the interaction of Taxwith Bcl3may contribute to the formation of the
ternary complex among Bcl3, coactivators and transcription factors,
and thereby regulate the genes for cell cycle progression in HTLV-1
infected cells.
Materials and methods
Reagents
The phosphatidylinositol 3-kinase (PI3K) inhibitor LY294002 and
20 S proteasome inhibitor MG132 were purchased from Calbiochem
(San Diego, CA). Cyclohexamide (CHX) was purchased from Sigma-
Aldrich (St. Louis, MO). Lithium chloride (LiCl) and cadmium chloride
(CdCl2) were purchased from WAKO (Osaka, Japan).
Antibodies
Rabbit polyclonal anti-Bcl3 antibody (C-14) was purchased from
Santa Cruz Biotechnology (San Diego, CA). Mouse monoclonal anti-
GAPDH antibodywas purchased fromMillipore (Billerica, MA). Rabbit
anti-Akt and anti-phosphorylated Akt (Ser473, Thr308) antibodies
were purchased from Cell Signaling Technology (Beverly, MA). Mouse
monoclonal anti-hemagglutinin (HA) antibody (HA-7)was purchased
from Sigma-Aldrich (St. Louis, MO). Mouse monoclonal anti-Tax
antibody (Lt-4) was kindly provided by Prof. Y. Tanaka (University of
the Ryukyus, Okinawa, Japan).
Cell culture
Six HTLV-1 infected cell lines (C5/MJ, HUT-102, MT-1, MT-2, MT-4,
and SLB-1) and three HTLV-1-uninfected T cell lines (CEM,MOLT-4, and
Jurkat) were used in this study. MT-2, MT-4, C5/MJ, and SLB-1 cell lines
are HTLV-1-transformed T cell lines established by an in vitro coculture
protocol. MT-2, MT-4 and C5/MJ are umbilical cord blood T cell lines,
whereas SLB-1 is an adult peripheral blood T cell line. HUT-102 was
established from a patient with ATL, but it is unclear whether HUT-102
cells represent an actual tumor clone from the donor ATL patient. MT-1
is a leukemic T cell line derived from a patient with ATL. The Tax-
inducible JPX-9 cell line is a derivative of the Jurkat cell line, which
expresses biologically active Tax protein under the control of the
metallothionein promoter (Nagata et al., 1989). These cells were
cultured in RPMI 1640 medium supplemented with 10% heat-
inactivated fetal bovine serum (FBS), 50 U/ml penicillin, and 50 µg/
ml streptomycin (Wako) at 37 °C in 5% CO2. 293 T cell is a human
embryonic kidney cell line, and was cultured in Dulbecco's
modiﬁed Eagle's medium (DMEM) supplemented with 10% FBS,
2 mM L-glutamine, 50 U/ml penicillin, and 50 µg/ml streptomycin
at 37 °C in 5% CO2.
Reverse transcriptase PCR (RT-PCR)
Total cellular RNA was extracted from human leukemic T cell lines
and HTLV-1-infected T cell lines by using RNeasy Mini Kit (QIAGEN,
Tokyo, Japan) according to the manufacturer's instructions. Comple-
mentary DNA (cDNA) was synthesized using TaqMan Reverse
Transcription kit (Applied Biosystems, Tokyo, Japan). For cDNA
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buffer, 22 µl MgCl2 (25 mM), 20 µl dNTPs mixture (at a ﬁnal
concentration of 500 µM each), 5 µl random hexamers (50 µM), 2 µl
RNase inhibitor (20 U/µl), and 2.5 µl (50 U/µl) Moloney murine
leukemia virus reverse transcriptase were added to a total volume of
100 µl. Samples were incubated at 25 °C for 10 min and 48 °C for
30 min, and reactions were stopped by heating to 95 °C for 5 min. For
ampliﬁcation of cDNA fragments corresponding Bcl3, Tax, and
GAPDH, 5 µl of cDNA solution were subjected to PCR ampliﬁcation
in a ﬁnal volume of 50 µl containing 10pM of each oligonucleotide
primer and 1× Premix Ex Taq (Takara Bio Inc., Shiga, Japan) in
accordance with manufacturer's protocol. The oligonucleotide pri-
mers used were as follows: 5′-GAA AAC AAC AGC CTT AGC ATG GT-3′
(sense) and 5′-CTG CGG AGT ACA TTT GCG-3′ (antisense) for Bcl3; 5′-
CGG ATA CCC AGT CTA CGT GT-3′ (sense) and 5′-GAG CCG ATA ACG
CGT CCA TCG-3′ (antisense) for Tax; and 5′-TGG AAG TTG CTG TTG
AAG TC-3′ (sense) and 5′-TCA AGA AGG TGG TGA AGC AG-3′
(antisense) for GAPDH. Ampliﬁed product sizes were 76 bp for Bcl3,
203 bp for Tax, and 100 bp for GAPDH. The ampliﬁcation programs
were as follows: 25 cycles of denaturing at 94 °C for 30 s, an annealing
step at 56 °C for 60 s, and an extension step at 72 °C for 90 s for Bcl3;
20 cycles of denaturing at 94 °C for 30 s, an annealing step at 56 °C for
60 s, and an extension step at 72 °C for 90 s for Tax; and 20 cycles of
denaturing at 94 °C for 30 s, an annealing step at 56 °C for 60 s, and an
extension step at 72 °C for 90 s for GAPDH. The PCR products were
fractionated in 2.5% agarose gels and visualized by ethidium bromide
staining.
Plasmids
Total cellular RNA was extracted from Jurkat cells and cDNA was
synthesized as described above. The ampliﬁcation of cDNA and
constructions of expression plasmids for wild type Bcl3were conducted
as reported by Hishiki et al. (Hishiki et al., 2007) with minor
modiﬁcations. For the ampliﬁcation of cDNA encoding wild type
human Bcl3, 5 µl of cDNA solution, 10pM of each oligonucleotide
primer, 1x PCR buffer, 0.4 mM dNTPs, 1U of KOD-FX DNA polymerase
(TOYOBO, Tokyo, Japan) were added to a total volume of 50 µl. The
ampliﬁcation programswere as follows: 1 cycle of denaturating at 94 °C
for 2 min, and then 30 cycles of denaturing at 98 °C for 10 s, annealing
and extension steps at 68 °C for 60 s. The sequences of oligonucleotides
primers are follows (lowercase letters indicate a linker sequence
containing EcoRI and XhoI sites, respectively): 5′-aaa gaa ttc ATG GAC
GAG GGG CCC GTG GAC-3′ and 5′-aaa ctc gag TCA GCT GCC TCC TGG
AGC TGG-3′. The ampliﬁed product encodingwild type human Bcl3was
inserted into the EcoRI and XhoI sites of the pcDNA3 (Invitrogen). Tax
expression vector pHβPr-1-neo-Tax1 and the empty vectorwere kindly
provided by Prof. M. Fujii (Niigata University, Niigata, Japan).
Western blot analysis
Cells were lysed in sodium dodecyl sulfate (SDS) sample buffer
containing 62.5 mM Tris–HCl (pH 6.8), 2% (wt/vol) SDS, 10%
glycerol, 6% 2-mercaptoethanol, and 0.01% bromophenol blue. The
lysates were resolved by electrophoresis on polyacrylamide gels
containing 0.1% SDS (SDS-PAGE) and then electroblotted onto
nitrocellulose membranes (Amersham Biosciences). Membranes
were blocked with 5% skim milk in PBS containing 0.05% tween 20
(PBS-Tween) overnight at 4 °C. The blots were exposed to the
appropriate ﬁrst antibody for 2 h and then washed with PBS-Tween
ﬁve times. After being washed, the blots were exposed to the
appropriate secondary antibody conjugated with horseradish per-
oxidase for 1 h at room temperature and then washed with PBS-
Tween ﬁve times. The reaction products were visualized using
enhanced chemiluminescence reagent (Amersham Biosciences)
according to the manufacturer's instructions.Lentiviral transduction of short hairpin RNA (shRNA)
Lentivirus-mediated short hairpin RNA (shRNA) was used to
knockdown Bcl3 in HTLV-1 infected human T cells by the method
reported by Saitoh et al. (Saitoh et al., 2008). For production of
lentiviruses, 5×105 293 T cells were plated in 6 cm-dish 24 h before
transfection. Cells were transfected with 0.5 µg of lentiviral vectors
expressing shRNA against human Bcl3 or control shRNA (Sigma-
Aldrich) together with 5 µl of Mission Lentiviral Packaging Mix
(Sigma-Aldrich), which containing vesicular stomatitis virus G
protein and the minimal set of lentiviral genes required to generate
the virion structural protein and packaging functions, by using
Lipofectamine LTX (Invitrogen) according to the manufacture's
protocol. Culture supernatants were collected 48 h after transfection
and ﬁltered. HTLV-1-infected HUT102 and C5/MJ cells were infected
with these lentiviruses for 16 h in the presence of 8 µg/ml polybrene
or remained uninfected as a control of parental cells. Then infected
and uninfected cells were suspended in ﬂesh RPMI1640 medium
containing 10% FBS and further incubated for 48 h. After 48 h
incubation, infected cells were cultured in RPMI1640 containing 10%
FBS in the presence of 1 µg/ml puromycin for an additional 48 h, other
than the control of parental cells. These two infectants and the control
parental cells were subjected to Western blotting to conﬁrm the
suppression of endogenous Bcl3 protein expression. These two
infectants and the control parental cells were also subjected to trypan
blue exclusion assay for the cell growth analysis. The number of viable
cells was determined every one day by counting trypan blue-
excluding cells in a hemocytometer.
Immunoprecipitation assay
For co-immunoprecipitation assay, 1×106 293 T cells were plated
in 6 cm-dishes in DMEM supplemented with 10% FBS 24 h before
transfection. After exchange to ﬂesh DMEM containing 10% FBS, cells
were transfected with 1 µg of pcDNA3 encoding wild type Bcl3
(pcDNA3–Bcl3) and 1 µg of pHβPr–1Tax1-neo or empty vector using
Lipofectamine LTX (Invitrogen) according to the manufacturer's
instructions. The cells were lysed in radio immune precipitation
(RIPA) buffer (50 mM Tris–HCl pH 8.0, 100 mM, NaCl, 1 mM EDTA,
0.5% Nonidet P-40) supplemented with a complete protease inhibitor
cocktail (Calbiochem). After removal of cell debris by centrifugation,
1 µg of each appropriate antibodywas added to lysate andmixedwith
a rotator for 16 h at 4 °C. Antibody-protein mixtures were then mixed
with 20 µl of protein G-Sepharose beads (Amersham Biosciences)
with the rotator for 2 h. The beads were thenwashed three times with
RIPA buffer and the immunoprecipitated proteins were resolved by
SDS-PAGE and analyzed by Western blotting with anti-Bcl3 antibody
(C-14) or anti-Tax monoclonal antibody (Lt-4). 1% of each lysate was
also subjected to Western blot analysis with each appropriate
antibody. For the immunoprecipitation of endogenous Tax protein
in HTLV-1-infected T cell lines, the cell lysates were prepared from
2×107 cells and immunoprecipitated with the non-immune rabbit
IgG or rabbit polyclonal anti-Bcl3 antibody (C-14), and subjected to
Western blot analysis with the anti-Tax antibody (Lt-4).
Statistical analyses
Statistical signiﬁcance was determined using the Student's t test
(unpaired, two-tailed). We considered Pb0.05 as statistically
signiﬁcant.
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